ロード中...
New Chimeric Antigen Receptor Design for Solid Tumors
In recent years, chimeric antigen receptor (CAR) T-cell therapy has become popular in immunotherapy, particularly after its tremendous success in the treatment of lineage-restricted hematologic cancers. However, the application of CAR T-cell therapy for solid tumors has not reached its full potentia...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5744429/ https://ncbi.nlm.nih.gov/pubmed/29312360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01934 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|